Skip to main content

Closed

PLRZ: Polyrizon Ltd. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+0.0% / yr

Operating margin0.0%

ROIC-29.8%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-2.0×

Current ratio29.03×

Polyrizon Ltd.

PLRZNASDAQ Global Market·USD·Closed

Polyrizon Ltd.

PLRZNASDAQ·USD·Closed

$11.25

−3.18%

$11.25

−$0.37 (3.18%)

52W Range

55thpctl

Volume

2.19×avg

Mkt Cap

12.60MUSD

P/E

-3.2TTM

Div Yield

–ann

52W Range

55thpctl

Volume

2.19×avg

Market Cap

12.60MUSD

P/E Ratio

-3.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings